Big Data in Pharma Marketing
[Published by FirstWord Pharma]
Published by FirstWord Pharma: 01 Jan 2013 | 33 | In Stock
Related Topics: Diabetes
Big data - the huge volume of digital data generated worldwide - continues to grow exponentially, opening up new opportunities and creating new challenges for the healthcare, pharmaceutical and biotech industries.
As society adapts to new activities and technologies that generate ever-greater quantities of data relevant to pharma, it is fast becoming a marketing tool that cannot be overlooked. Exactly how best to use big data has yet to be established, but recent research indicates its potential worth in market research, product pricing, patient support and education, and more. The very scale of big data and the difficulty of working with it pose difficult questions about data capture standards and the protection of privacy while accessing invaluable information. Who, for example, provides the expertise?
This comprehensive study will prove an essential companion for anyone hoping to understand big data and its role in pharma marketing.
For this essential report, FirstWord consulted experts on the analysis and application of big data such as Duncan Ross, Director of Data Science at Teradata, a company that works in data management, data gathering and data analysis, for their views, which inform a document that guides the reader through every facet of a complex and ever-expanding subject.
The report opens with a broad definition of big data and goes on to examine the subject in great detail, from looking at its sources to explaining how it is being used as a marketing tool.
Sections on usage in other industries and on the issues and challenges it raises will ensure the reader is fully briefed on big data and how to work with it.
Key Report Features
Key Questions Answered
Who Should Read This Report
Expert Views Include:
Nic Brereton, Founder and director at BresMed Health
Chris Winchester, deputy managing director at Oxford PharmaGenesis
Dennis Urbaniak, VP, US Diabetes at Sanofi US
Destry Sulkes, executive vice president and co-founder of Medivo
Mark Divers, head of the Karolinska Institutet biobank
Michael Doyle, director of marketing at Accelrys
Joel Dudley, assistant professor of genetics and genomic sciences and director of biomedical informatics at Mount Sinai School of Medicine
Duncan Ross, director of data science at Teradata
Jan-Eric Litton, professor, department of medical epidemiology and biostatistics, Karolinska Institutet
Jonathan Peachey, head of consulting, Kinapse
Andy Black, co-founder and chief executive officer, Kinapse
Ryan Peeler, director at Lnx Research
Dream Samir, managing director at Merck Serono
"Big data isn't just about the amount of data, it's about having the means to analyse the data, and gain knowledge and insights from the whole dataset, not just a bit at a time. It's also about combining multiple data sources and learning from the relationships across these." Joel Dudley, assistant professor of genetics and genomic sciences and director of biomedical informatics at Mount Sinai School of Medicine
"Big data’s real sweet spot is around innovation, and innovation always has an element of risk associated with it. Failing fast is important – you want to identify the approaches that are heading towards value and very quickly discard the ones that aren't.” Duncan Ross, Director of Data Science at Teradata
"There are lots of software developers and engineers who were not working in the healthcare arena but love working with data to find new solutions, and they and their platforms can easily be transferred over into our industry." Dennis Urbaniak, VP, US Diabetes at Sanofi US
"There is potential for companies to be able to differentiate themselves and their products through big information." Jonathan Peachey, head of consulting, Kinapse
Table of Contents
for Big Data in Pharma Marketing [Published by FirstWord Pharma]
1. The big data explosion
2. Knowing what big data means
Big data is everywhere
2.1. Clinical trials as a resource for big data analysis
2.2. Mining patient data from electronic records and registers
2.3. Social media as a source to understand the individual
2.4. 'Quantified self': Self-sourced data tracking in real time
2.5. Sales and marketing data sources add to the dataset
3. The role of analysis in big data-led marketing
Using big data to support pharma marketing
3.1. Big data's role in knowing your customer and market
3.2. Using big data to tailor drug messaging
3.3. Big data can support product pricing
3.4. Keeping and growing customer loyalty
3.5. Big data's role in support and education
3.6. Using big data to support peer-to-peer marketing
3.7. Improving the industry image through big data
Learning from other industries
3.8. 'Gamification': Having fun and creating data
The challenges inherent in big data
3.9. Big data means big investments but big value
3.10. Big data for marketing relies on the right skills
3.11. Data standardisation as an important step
3.12. The challenge of big data approaches in social media
3.13. Data privacy, security and ownership is a sensitive issue
3.14. Only the right questions get the right answer
3.15. Dealing with big data fallout
Big data in pharma marketing: Present and future
Number of Pages
|Title||Date Published||Price from||More Details|
|Physician Views: New data for Novartis LCZ696 set the Street abuzz, but how do cardiologists see it fitting into highly genericised heart failure market?|
Scope The potential blockbuster status of Novartis' LCZ696 has seemingly been cemented in the eyes o...
|03 Sep 3014 by FirstWord Pharma||USD $695||More Info|
|Physician Views: What impact will new Kyprolis data have on MM treatment paradigm?|
Scope Amgen has been under fire ever since announcing plans to acquire Onyx for .4 billion as the...
|08 Mar 2015 by FirstWord Pharma||USD $695||More Info|
|Physician Views: Reaction to Bristol-Myers Squibb's Opdivo data in non-small-cell lung cancer|
Scope Studies of Bristol-Myers Squibb's PD-1 inhibitor nivolumab in non-small-cell lung cancer (NSCL...
|06 Nov 2014 by FirstWord Pharma||USD $695||More Info|
|Physician Views: Gilead's Phase III tenofovir alafenamide (TAF) data in HIV – an initial assessment|
Scope Following publication of the first Phase III data for Gilead Sciences' HIV therapy tenofovir a...
|01 Oct 2014 by FirstWord Pharma||USD $695||More Info|
|Physician Views: How do oncologists expect use of Kyprolis will be affected by Amgen's positive ASPIRE data?|
Scope When Amgen paid .4 billion for Onyx Pharmaceuticals last fall it did so based on the belief...
|14 Aug 2014 by FirstWord Pharma||USD $695||More Info|
|Physician Views – Are oncologists ready to embrace real-world data?|
Scope As pharma looks to both improve the efficiencies of its operating models and deliver more comp...
|15 Apr 2014 by FirstWord Pharma||USD $695||More Info|
|Physician Views: Oncologist reaction to Roche's Gazyva – US approval and new late-stage data versus Rituxan|
Scope Roche’s efforts to enhance its dominance of the haematological cancer market received notable ...
|01 Nov 2013 by FirstWord Pharma||USD $695||More Info|
|Strategies for Working With Real World Data|
IntroductionReal world data (RWD)—it’s a never-ending wave of information that is, increasingly, tra...
|01 Oct 2013 by FirstWord Pharma||USD $695||More Info|
|Physician Views: What is reaction among urologists, oncologists to the Xtandi PREVAIL data – can it displace Zytiga in the pre-chemotherapy prostate cancer setting?|
ScopeThe prostate cancer market looks poised to enter its next stage of evolution in 2014, with Medi...
|01 Oct 2013 by FirstWord Pharma||USD $695||More Info|
|Managing Real World Data|
IntroductionPharma companies are no longer the sole owners and controllers of the information that d...
|01 Oct 2012 by FirstWord Pharma||USD $695||More Info|
This report is published by FirstWord Pharma
Download Free Report Summary PDF
Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.
Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.
Accepted Card Types
Buy now using our secure payment system.